Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 156 Pages
Report ld: 2694431
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Budesonide Market Size(US$)
CAGR 2024-2030
3.2%
Market Size,2030
USD 10,250
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 8,487.8 million
Market Forecast in 2030(Value)
US$ 10,250 million
CAGR
3.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
The global Budesonide market size was US$ 8203 million in 2023 and is forecast to a readjusted size of US$ 10250 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
In terms of sales (consumption) side, this report focuses on the sales of Budesonide by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Budesonide market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Budesonide market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- AstraZeneca
- Teva
- Mylan
- Sandoz
- Cosmo Pharmaceuticals
- Salix
- Chiesi Farmaceutici
- Orion Corporation
- Cipla
- Synmosa Biopharma
- Lunan Better Pharma
- Shanghai Sine Promod
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Injectable Suspension
- Aerosols
- Inhalation Powder
- Tablet and Capsule
Segment by Application
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Budesonide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Budesonide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Budesonide Definition
1.2 Market by Type
1.2.1 Global Budesonide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Market Segment by Application
1.3.1 Global Budesonide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Budesonide Sales
2.1 Global Budesonide Revenue Estimates and Forecasts 2019-2030
2.2 Global Budesonide Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Budesonide Revenue by Region
2.3.1 Global Budesonide Revenue by Region (2019-2024)
2.3.2 Global Budesonide Revenue by Region (2025-2030)
2.4 Global Budesonide Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Budesonide Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Budesonide Sales Quantity by Region
2.6.1 Global Budesonide Sales Quantity by Region (2019-2024)
2.6.2 Global Budesonide Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Budesonide Sales Quantity by Manufacturers
3.1.1 Global Budesonide Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Budesonide Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Budesonide Sales in 2023
3.2 Global Budesonide Revenue by Manufacturers
3.2.1 Global Budesonide Revenue by Manufacturers (2019-2024)
3.2.2 Global Budesonide Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Budesonide Revenue in 2023
3.3 Global Budesonide Sales Price by Manufacturers
3.4 Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Budesonide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Budesonide, Product Offered and Application
3.8 Global Key Manufacturers of Budesonide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Budesonide Sales Quantity by Type
4.1.1 Global Budesonide Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Budesonide Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Budesonide Sales Quantity Market Share by Type (2019-2030)
4.2 Global Budesonide Revenue by Type
4.2.1 Global Budesonide Historical Revenue by Type (2019-2024)
4.2.2 Global Budesonide Forecasted Revenue by Type (2025-2030)
4.2.3 Global Budesonide Revenue Market Share by Type (2019-2030)
4.3 Global Budesonide Price by Type
4.3.1 Global Budesonide Price by Type (2019-2024)
4.3.2 Global Budesonide Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Budesonide Sales Quantity by Application
5.1.1 Global Budesonide Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Budesonide Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Budesonide Sales Quantity Market Share by Application (2019-2030)
5.2 Global Budesonide Revenue by Application
5.2.1 Global Budesonide Historical Revenue by Application (2019-2024)
5.2.2 Global Budesonide Forecasted Revenue by Application (2025-2030)
5.2.3 Global Budesonide Revenue Market Share by Application (2019-2030)
5.3 Global Budesonide Price by Application
5.3.1 Global Budesonide Price by Application (2019-2024)
5.3.2 Global Budesonide Price Forecast by Application (2025-2030)
6 North America
6.1 North America Budesonide Sales by Company
6.1.1 North America Budesonide Revenue by Company (2019-2024)
6.1.2 North America Budesonide Sales Quantity by Company (2019-2024)
6.2 North America Budesonide Market Size by Type
6.2.1 North America Budesonide Sales Quantity by Type (2019-2030)
6.2.2 North America Budesonide Revenue by Type (2019-2030)
6.3 North America Budesonide Market Size by Application
6.3.1 North America Budesonide Sales Quantity by Application (2019-2030)
6.3.2 North America Budesonide Revenue by Application (2019-2030)
6.4 North America Budesonide Market Size by Country
6.4.1 North America Budesonide Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Budesonide Revenue by Country (2019-2030)
6.4.3 North America Budesonide Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Budesonide Sales by Company
7.1.1 Europe Budesonide Sales Quantity by Company (2019-2024)
7.1.2 Europe Budesonide Revenue by Company (2019-2024)
7.2 Europe Budesonide Market Size by Type
7.2.1 Europe Budesonide Sales Quantity by Type (2019-2030)
7.2.2 Europe Budesonide Revenue by Type (2019-2030)
7.3 Europe Budesonide Market Size by Application
7.3.1 Europe Budesonide Sales Quantity by Application (2019-2030)
7.3.2 Europe Budesonide Revenue by Application (2019-2030)
7.4 Europe Budesonide Market Size by Country
7.4.1 Europe Budesonide Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Budesonide Revenue by Country (2019-2030)
7.4.3 Europe Budesonide Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Budesonide Sales by Company
8.1.1 China Budesonide Sales Quantity by Company (2019-2024)
8.1.2 China Budesonide Revenue by Company (2019-2024)
8.2 China Budesonide Market Size by Type
8.2.1 China Budesonide Sales Quantity by Type (2019-2030)
8.2.2 China Budesonide Revenue by Type (2019-2030)
8.3 China Budesonide Market Size by Application
8.3.1 China Budesonide Sales Quantity by Application (2019-2030)
8.3.2 China Budesonide Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Budesonide Sales by Company
9.1.1 APAC Budesonide Sales Quantity by Company (2019-2024)
9.1.2 APAC Budesonide Revenue by Company (2019-2024)
9.2 APAC Budesonide Market Size by Type
9.2.1 APAC Budesonide Sales Quantity by Type (2019-2030)
9.2.2 APAC Budesonide Revenue by Type (2019-2030)
9.3 APAC Budesonide Market Size by Application
9.3.1 APAC Budesonide Sales Quantity by Application (2019-2030)
9.3.2 APAC Budesonide Revenue by Application (2019-2030)
9.4 APAC Budesonide Market Size by Region
9.4.1 APAC Budesonide Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Budesonide Revenue by Region (2019-2030)
9.4.3 APAC Budesonide Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Budesonide Sales by Company
10.1.1 Middle East, Africa and Latin America Budesonide Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Budesonide Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Budesonide Market Size by Type
10.2.1 Middle East, Africa and Latin America Budesonide Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Budesonide Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Budesonide Market Size by Application
10.3.1 Middle East, Africa and Latin America Budesonide Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Budesonide Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Budesonide Market Size by Country
10.4.1 Middle East, Africa and Latin America Budesonide Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Budesonide Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Budesonide Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 AstraZeneca Budesonide Products and Services
11.1.5 AstraZeneca Budesonide SWOT Analysis
11.1.6 AstraZeneca Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Teva Budesonide Products and Services
11.2.5 Teva Budesonide SWOT Analysis
11.2.6 Teva Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Mylan Budesonide Products and Services
11.3.5 Mylan Budesonide SWOT Analysis
11.3.6 Mylan Recent Developments
11.4 Sandoz
11.4.1 Sandoz Company Information
11.4.2 Sandoz Overview
11.4.3 Sandoz Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Sandoz Budesonide Products and Services
11.4.5 Sandoz Budesonide SWOT Analysis
11.4.6 Sandoz Recent Developments
11.5 Cosmo Pharmaceuticals
11.5.1 Cosmo Pharmaceuticals Company Information
11.5.2 Cosmo Pharmaceuticals Overview
11.5.3 Cosmo Pharmaceuticals Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Cosmo Pharmaceuticals Budesonide Products and Services
11.5.5 Cosmo Pharmaceuticals Budesonide SWOT Analysis
11.5.6 Cosmo Pharmaceuticals Recent Developments
11.6 Salix
11.6.1 Salix Company Information
11.6.2 Salix Overview
11.6.3 Salix Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Salix Budesonide Products and Services
11.6.5 Salix Budesonide SWOT Analysis
11.6.6 Salix Recent Developments
11.7 Chiesi Farmaceutici
11.7.1 Chiesi Farmaceutici Company Information
11.7.2 Chiesi Farmaceutici Overview
11.7.3 Chiesi Farmaceutici Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Chiesi Farmaceutici Budesonide Products and Services
11.7.5 Chiesi Farmaceutici Budesonide SWOT Analysis
11.7.6 Chiesi Farmaceutici Recent Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Company Information
11.8.2 Orion Corporation Overview
11.8.3 Orion Corporation Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Orion Corporation Budesonide Products and Services
11.8.5 Orion Corporation Budesonide SWOT Analysis
11.8.6 Orion Corporation Recent Developments
11.9 Cipla
11.9.1 Cipla Company Information
11.9.2 Cipla Overview
11.9.3 Cipla Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Cipla Budesonide Products and Services
11.9.5 Cipla Budesonide SWOT Analysis
11.9.6 Cipla Recent Developments
11.10 Synmosa Biopharma
11.10.1 Synmosa Biopharma Company Information
11.10.2 Synmosa Biopharma Overview
11.10.3 Synmosa Biopharma Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Synmosa Biopharma Budesonide Products and Services
11.10.5 Synmosa Biopharma Budesonide SWOT Analysis
11.10.6 Synmosa Biopharma Recent Developments
11.11 Lunan Better Pharma
11.11.1 Lunan Better Pharma Company Information
11.11.2 Lunan Better Pharma Overview
11.11.3 Lunan Better Pharma Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 Lunan Better Pharma Budesonide Products and Services
11.11.5 Lunan Better Pharma Recent Developments
11.12 Shanghai Sine Promod
11.12.1 Shanghai Sine Promod Company Information
11.12.2 Shanghai Sine Promod Overview
11.12.3 Shanghai Sine Promod Budesonide Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.12.4 Shanghai Sine Promod Budesonide Products and Services
11.12.5 Shanghai Sine Promod Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Budesonide Value Chain Analysis
12.2 Budesonide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Budesonide Production Mode & Process
12.4 Budesonide Sales and Marketing
12.4.1 Budesonide Sales Channels
12.4.2 Budesonide Distributors
12.5 Budesonide Customers
13 Market Dynamics
13.1 Budesonide Industry Trends
13.2 Budesonide Market Drivers
13.3 Budesonide Market Challenges
13.4 Budesonide Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Budesonide Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Injectable Suspension
Table 3. Major Manufacturers of Aerosols
Table 4. Major Manufacturers of Inhalation Powder
Table 5. Major Manufacturers of Tablet and Capsule
Table 6. Global Budesonide Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Budesonide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Budesonide Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Budesonide Revenue Market Share by Region (2019-2024)
Table 10. Global Budesonide Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Budesonide Revenue Market Share by Region (2025-2030)
Table 12. Global Budesonide Sales Quantity by Region: 2019 VS 2023 VS 2030 (M Units)
Table 13. Global Budesonide Sales by Region (2019-2024) & (M Units)
Table 14. Global Budesonide Sales Market Share by Region (2019-2024)
Table 15. Global Budesonide Sales by Region (2025-2030) & (M Units)
Table 16. Global Budesonide Sales Market Share by Region (2025-2030)
Table 17. Global Budesonide Sales Quantity by Manufacturers (2019-2024) & (M Units)
Table 18. Global Budesonide Sales Quantity Share by Manufacturers (2019-2024)
Table 19. Global Budesonide Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Budesonide Revenue Share by Manufacturers (2019-2024)
Table 21. Global Budesonide Price by Manufacturers 2019-2024 (USD/K Units)
Table 22. Global Key Players of Budesonide, Industry Ranking, 2022 VS 2023
Table 23. Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Budesonide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2023)
Table 25. Global Key Manufacturers of Budesonide, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Budesonide, Product Offered and Application
Table 27. Global Key Manufacturers of Budesonide, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Budesonide Sales Quantity by Type (2019-2024) & (M Units)
Table 30. Global Budesonide Sales Quantity by Type (2025-2030) & (M Units)
Table 31. Global Budesonide Sales Quantity Share by Type (2019-2024)
Table 32. Global Budesonide Sales Quantity Share by Type (2025-2030)
Table 33. Global Budesonide Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Budesonide Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Budesonide Revenue Share by Type (2019-2024)
Table 36. Global Budesonide Revenue Share by Type (2025-2030)
Table 37. Budesonide Price by Type (2019-2024) & (USD/K Units)
Table 38. Global Budesonide Price Forecast by Type (2025-2030) & (USD/K Units)
Table 39. Global Budesonide Sales Quantity by Application (2019-2024) & (M Units)
Table 40. Global Budesonide Sales Quantity by Application (2025-2030) & (M Units)
Table 41. Global Budesonide Sales Quantity Share by Application (2019-2024)
Table 42. Global Budesonide Sales Quantity Share by Application (2025-2030)
Table 43. Global Budesonide Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Budesonide Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Budesonide Revenue Share by Application (2019-2024)
Table 46. Global Budesonide Revenue Share by Application (2025-2030)
Table 47. Budesonide Price by Application (2019-2024) & (USD/K Units)
Table 48. Global Budesonide Price Forecast by Application (2025-2030) & (USD/K Units)
Table 49. North America Budesonide Revenue by Company (2019-2024) & (US$ Million)
Table 50. North America Budesonide Sales Quantity by Company (2019-2024) & (M Units)
Table 51. North America Budesonide Sales Quantity by Type (2019-2024) & (M Units)
Table 52. North America Budesonide Sales Quantity by Type (2025-2030) & (M Units)
Table 53. North America Budesonide Revenue by Type (2019-2024) & (US$ Million)
Table 54. North America Budesonide Revenue by Type (2025-2030) & (US$ Million)
Table 55. North America Budesonide Sales Quantity by Application (2019-2024) & (M Units)
Table 56. North America Budesonide Sales Quantity by Application (2025-2030) & (M Units)
Table 57. North America Budesonide Revenue by Application (2019-2024) & (US$ Million)
Table 58. North America Budesonide Revenue by Application (2025-2030) & (US$ Million)
Table 59. North America Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 60. North America Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 61. North America Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 62. North America Budesonide Sales Quantity by Country (2019-2024) & (M Units)
Table 63. North America Budesonide Sales Quantity by Country (2025-2030) & (M Units)
Table 64. Europe Budesonide Sales Quantity by Company (2019-2024) & (M Units)
Table 65. Europe Budesonide Revenue by Company (2019-2024) & (US$ Million)
Table 66. Europe Budesonide Sales Quantity by Type (2019-2024) & (M Units)
Table 67. Europe Budesonide Sales Quantity by Type (2025-2030) & (M Units)
Table 68. Europe Budesonide Revenue by Type (2019-2024) & (US$ Million)
Table 69. Europe Budesonide Revenue by Type (2025-2030) & (US$ Million)
Table 70. Europe Budesonide Sales Quantity by Application (2019-2024) & (M Units)
Table 71. Europe Budesonide Sales Quantity by Application (2025-2030) & (M Units)
Table 72. Europe Budesonide Revenue by Application (2019-2024) & (US$ Million)
Table 73. Europe Budesonide Revenue by Application (2025-2030) & (US$ Million)
Table 74. Europe Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 75. Europe Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 76. Europe Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 77. Europe Budesonide Sales Quantity by Country (2019-2024) & (M Units)
Table 78. Europe Budesonide Sales Quantity by Country (2025-2030) & (M Units)
Table 79. China Budesonide Sales Quantity by Company (2019-2024) & (M Units)
Table 80. China Budesonide Revenue by Company (2019-2024) & (US$ Million)
Table 81. China Budesonide Sales Quantity by Type (2019-2024) & (M Units)
Table 82. China Budesonide Sales Quantity by Type (2025-2030) & (M Units)
Table 83. China Budesonide Revenue by Type (2019-2024) & (US$ Million)
Table 84. China Budesonide Revenue by Type (2025-2030) & (US$ Million)
Table 85. China Budesonide Sales Quantity by Application (2019-2024) & (M Units)
Table 86. China Budesonide Sales Quantity by Application (2025-2030) & (M Units)
Table 87. China Budesonide Revenue by Application (2019-2024) & (US$ Million)
Table 88. China Budesonide Revenue by Application (2025-2030) & (US$ Million)
Table 89. APAC Budesonide Sales Quantity by Company (2019-2024) & (M Units)
Table 90. APAC Budesonide Revenue by Company (2019-2024) & (US$ Million)
Table 91. APAC Budesonide Sales Quantity by Type (2019-2024) & (M Units)
Table 92. APAC Budesonide Sales Quantity by Type (2025-2030) & (M Units)
Table 93. APAC Budesonide Revenue by Type (2019-2024) & (US$ Million)
Table 94. APAC Budesonide Revenue by Type (2025-2030) & (US$ Million)
Table 95. APAC Budesonide Sales Quantity by Application (2019-2024) & (M Units)
Table 96. APAC Budesonide Sales Quantity by Application (2025-2030) & (M Units)
Table 97. APAC Budesonide Revenue by Application (2019-2024) & (US$ Million)
Table 98. APAC Budesonide Revenue by Application (2025-2030) & (US$ Million)
Table 99. APAC Budesonide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 100. APAC Budesonide Revenue by Region (2019-2024) & (US$ Million)
Table 101. APAC Budesonide Revenue by Region (2025-2030) & (US$ Million)
Table 102. APAC Budesonide Sales Quantity by Region (2019-2024) & (M Units)
Table 103. APAC Budesonide Sales Quantity by Region (2025-2030) & (M Units)
Table 104. Middle East, Africa and Latin America Budesonide Sales Quantity by Company (2019-2024) & (M Units)
Table 105. Middle East, Africa and Latin America Budesonide Revenue by Company (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Budesonide Sales Quantity by Type (2019-2024) & (M Units)
Table 107. Middle East, Africa and Latin America Budesonide Sales Quantity by Type (2025-2030) & (M Units)
Table 108. Middle East, Africa and Latin America Budesonide Revenue by Type (2019-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Budesonide Revenue by Type (2025-2030) & (US$ Million)
Table 110. Middle East, Africa and Latin America Budesonide Sales Quantity by Application (2019-2024) & (M Units)
Table 111. Middle East, Africa and Latin America Budesonide Sales Quantity by Application (2025-2030) & (M Units)
Table 112. Middle East, Africa and Latin America Budesonide Revenue by Application (2019-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Budesonide Revenue by Application (2025-2030) & (US$ Million)
Table 114. Middle East, Africa and Latin America Budesonide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 115. Middle East, Africa and Latin America Budesonide Revenue by Country (2019-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Budesonide Revenue by Country (2025-2030) & (US$ Million)
Table 117. Middle East, Africa and Latin America Budesonide Sales Quantity by Country (2019-2024) & (M Units)
Table 118. Middle East, Africa and Latin America Budesonide Sales Quantity by Country (2025-2030) & (M Units)
Table 119. AstraZeneca Company Information
Table 120. AstraZeneca Description and Overview
Table 121. AstraZeneca Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 122. AstraZeneca Budesonide Product and Services
Table 123. AstraZeneca Budesonide SWOT Analysis
Table 124. AstraZeneca Recent Developments
Table 125. Teva Company Information
Table 126. Teva Description and Overview
Table 127. Teva Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 128. Teva Budesonide Product and Services
Table 129. Teva Budesonide SWOT Analysis
Table 130. Teva Recent Developments
Table 131. Mylan Company Information
Table 132. Mylan Description and Overview
Table 133. Mylan Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 134. Mylan Budesonide Product and Services
Table 135. Mylan Budesonide SWOT Analysis
Table 136. Mylan Recent Developments
Table 137. Sandoz Company Information
Table 138. Sandoz Description and Overview
Table 139. Sandoz Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 140. Sandoz Budesonide Product and Services
Table 141. Sandoz Budesonide SWOT Analysis
Table 142. Sandoz Recent Developments
Table 143. Cosmo Pharmaceuticals Company Information
Table 144. Cosmo Pharmaceuticals Description and Overview
Table 145. Cosmo Pharmaceuticals Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 146. Cosmo Pharmaceuticals Budesonide Product and Services
Table 147. Cosmo Pharmaceuticals Budesonide SWOT Analysis
Table 148. Cosmo Pharmaceuticals Recent Developments
Table 149. Salix Company Information
Table 150. Salix Description and Overview
Table 151. Salix Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 152. Salix Budesonide Product and Services
Table 153. Salix Budesonide SWOT Analysis
Table 154. Salix Recent Developments
Table 155. Chiesi Farmaceutici Company Information
Table 156. Chiesi Farmaceutici Description and Overview
Table 157. Chiesi Farmaceutici Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 158. Chiesi Farmaceutici Budesonide Product and Services
Table 159. Chiesi Farmaceutici Budesonide SWOT Analysis
Table 160. Chiesi Farmaceutici Recent Developments
Table 161. Orion Corporation Company Information
Table 162. Orion Corporation Description and Overview
Table 163. Orion Corporation Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 164. Orion Corporation Budesonide Product and Services
Table 165. Orion Corporation Budesonide SWOT Analysis
Table 166. Orion Corporation Recent Developments
Table 167. Cipla Company Information
Table 168. Cipla Description and Overview
Table 169. Cipla Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 170. Cipla Budesonide Product and Services
Table 171. Cipla Budesonide SWOT Analysis
Table 172. Cipla Recent Developments
Table 173. Synmosa Biopharma Company Information
Table 174. Synmosa Biopharma Description and Overview
Table 175. Synmosa Biopharma Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 176. Synmosa Biopharma Budesonide Product and Services
Table 177. Synmosa Biopharma Budesonide SWOT Analysis
Table 178. Synmosa Biopharma Recent Developments
Table 179. Lunan Better Pharma Company Information
Table 180. Lunan Better Pharma Description and Overview
Table 181. Lunan Better Pharma Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 182. Lunan Better Pharma Budesonide Product and Services
Table 183. Lunan Better Pharma Recent Developments
Table 184. Shanghai Sine Promod Company Information
Table 185. Shanghai Sine Promod Description and Overview
Table 186. Shanghai Sine Promod Budesonide Sales Quantity (M Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/K Units) and Gross Margin (2019-2024)
Table 187. Shanghai Sine Promod Budesonide Product and Services
Table 188. Shanghai Sine Promod Recent Developments
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Budesonide Distributors List
Table 192. Budesonide Customers List
Table 193. Budesonide Market Trends
Table 194. Budesonide Market Drivers
Table 195. Budesonide Market Challenges
Table 196. Budesonide Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Budesonide Market Share by Type in 2023 & 2030
Figure 4. Injectable Suspension Product Picture
Figure 5. Aerosols Product Picture
Figure 6. Inhalation Powder Product Picture
Figure 7. Tablet and Capsule Product Picture
Figure 8. Global Budesonide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Budesonide Market Share by Application in 2023 & 2030
Figure 10. Respiratory Disease Treatment
Figure 11. Nose Disease Treatment
Figure 12. Inflammatory Bowel Disease Treatment
Figure 13. Others
Figure 14. Budesonide Report Years Considered
Figure 15. Global Budesonide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Budesonide Revenue 2019-2030 (US$ Million)
Figure 17. Global Budesonide Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 18. Global Budesonide Sales Quantity 2019-2030 (M Units)
Figure 19. Global Budesonide Sales Quantity Market Share by Region (2019-2024)
Figure 20. Global Budesonide Sales Quantity Market Share by Region (2025-2030)
Figure 21. North America Budesonide Sales Quantity YoY (2019-2030) & (M Units)
Figure 22. North America Budesonide Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Europe Budesonide Sales Quantity YoY (2019-2030) & (M Units)
Figure 24. Europe Budesonide Revenue YoY (2019-2030) & (US$ Million)
Figure 25. China Budesonide Sales Quantity YoY (2019-2030) & (M Units)
Figure 26. China Budesonide Revenue YoY (2019-2030) & (US$ Million)
Figure 27. APAC Budesonide Sales Quantity YoY (2019-2030) & (M Units)
Figure 28. APAC Budesonide Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Budesonide Sales Quantity YoY (2019-2030) & (M Units)
Figure 30. Middle East, Africa and Latin America Budesonide Revenue YoY (2019-2030) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Budesonide Sales Quantity in 2023
Figure 32. The Top 10 and Top 5 Players Market Share by Budesonide Revenue in 2023
Figure 33. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 34. Global Budesonide Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Budesonide Revenue Market Share by Type (2019-2030)
Figure 36. Global Budesonide Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Budesonide Revenue Market Share by Application (2019-2030)
Figure 38. North America Budesonide Revenue Market Share by Company in 2023
Figure 39. North America Budesonide Sales Quantity Market Share by Company in 2023
Figure 40. North America Budesonide Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Budesonide Revenue Market Share by Type (2019-2030)
Figure 42. North America Budesonide Sales Quantity Market Share by Application (2019-2030)
Figure 43. North America Budesonide Revenue Market Share by Application (2019-2030)
Figure 44. North America Budesonide Revenue Share by Country (2019-2030)
Figure 45. North America Budesonide Sales Quantity Share by Country (2019-2030)
Figure 46. U.S. Budesonide Revenue (2019-2030) & (US$ Million)
Figure 47. Canada Budesonide Revenue (2019-2030) & (US$ Million)
Figure 48. Europe Budesonide Sales Quantity Market Share by Company in 2023
Figure 49. Europe Budesonide Revenue Market Share by Company in 2023
Figure 50. Europe Budesonide Sales Quantity Market Share by Type (2019-2030)
Figure 51. Europe Budesonide Revenue Market Share by Type (2019-2030)
Figure 52. Europe Budesonide Sales Quantity Market Share by Application (2019-2030)
Figure 53. Europe Budesonide Revenue Market Share by Application (2019-2030)
Figure 54. Europe Budesonide Revenue Share by Country (2019-2030)
Figure 55. Europe Budesonide Sales Quantity Share by Country (2019-2030)
Figure 56. Germany Budesonide Revenue (2019-2030) & (US$ Million)
Figure 57. France Budesonide Revenue (2019-2030) & (US$ Million)
Figure 58. U.K. Budesonide Revenue (2019-2030) & (US$ Million)
Figure 59. Italy Budesonide Revenue (2019-2030) & (US$ Million)
Figure 60. Russia Budesonide Revenue (2019-2030) & (US$ Million)
Figure 61. China Budesonide Sales Quantity Market Share by Company in 2023
Figure 62. China Budesonide Revenue Market Share by Company in 2023
Figure 63. China Budesonide Sales Quantity Market Share by Type (2019-2030)
Figure 64. China Budesonide Revenue Market Share by Type (2019-2030)
Figure 65. China Budesonide Sales Quantity Market Share by Application (2019-2030)
Figure 66. China Budesonide Revenue Market Share by Application (2019-2030)
Figure 67. APAC Budesonide Sales Quantity Market Share by Company in 2023
Figure 68. APAC Budesonide Revenue Market Share by Company in 2023
Figure 69. APAC Budesonide Sales Quantity Market Share by Type (2019-2030)
Figure 70. APAC Budesonide Revenue Market Share by Type (2019-2030)
Figure 71. APAC Budesonide Sales Quantity Market Share by Application (2019-2030)
Figure 72. APAC Budesonide Revenue Market Share by Application (2019-2030)
Figure 73. APAC Budesonide Revenue Share by Region (2019-2030)
Figure 74. APAC Budesonide Sales Quantity Share by Region (2019-2030)
Figure 75. Japan Budesonide Revenue (2019-2030) & (US$ Million)
Figure 76. South Korea Budesonide Revenue (2019-2030) & (US$ Million)
Figure 77. China Taiwan Budesonide Revenue (2019-2030) & (US$ Million)
Figure 78. Southeast Asia Budesonide Revenue (2019-2030) & (US$ Million)
Figure 79. India Budesonide Revenue (2019-2030) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Budesonide Sales Quantity Market Share by Company in 2023
Figure 81. Middle East, Africa and Latin America Budesonide Revenue Market Share by Company in 2023
Figure 82. Middle East, Africa and Latin America Budesonide Sales Quantity Market Share by Type (2019-2030)
Figure 83. Middle East, Africa and Latin America Budesonide Revenue Market Share by Type (2019-2030)
Figure 84. Middle East, Africa and Latin America Budesonide Sales Quantity Market Share by Application (2019-2030)
Figure 85. Middle East, Africa and Latin America Budesonide Revenue Market Share by Application (2019-2030)
Figure 86. Middle East, Africa and Latin America Budesonide Sales Quantity Share by Country (2019-2030)
Figure 87. Middle East, Africa and Latin America Budesonide Revenue Share by Country (2019-2030)
Figure 88. Brazil Budesonide Revenue (2019-2030) & (US$ Million)
Figure 89. Mexico Budesonide Revenue (2019-2030) & (US$ Million)
Figure 90. Turkey Budesonide Revenue (2019-2030) & (US$ Million)
Figure 91. Israel Budesonide Revenue (2019-2030) & (US$ Million)
Figure 92. GCC Countries Budesonide Revenue (2019-2030) & (US$ Million)
Figure 93. Budesonide Value Chain
Figure 94. Budesonide Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Budesonide market size from 2024 to 2030?
The annual compound growth rate of the global Budesonide market is 3.2% 2024 to 2030.
What was the global market size of Budesonide in 2030?
Which companies rank high in the global Budesonide market?
What was the global market size of Budesonide in 2024?
Which region is expected to have the highest market share?
Related Reports
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-08
Pages: 205
USD 4900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
Published Date: 2026-07-08
Pages: 170
USD 4250.00
(Single User License)
Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 155
USD 2900.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 167
USD 3950.00
(Single User License)
Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published Date: 2026-06-17
Pages: 133
USD 3350.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 153
USD 4900.00
(Single User License)
Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 126
USD 3950.00
(Single User License)
Global Budesonide Market Research Report 2025
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-08
Pages: 205
USD 4900.00 (Single User License)Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
Published: 2026-07-08
Pages: 170
USD 4250.00 (Single User License)Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 155
USD 2900.00 (Single User License)Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 167
USD 3950.00 (Single User License)Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published: 2026-06-17
Pages: 133
USD 3350.00 (Single User License)Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 153
USD 4900.00 (Single User License)Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00 (Single User License)Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
USD 4250.00 (Single User License)Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 126
USD 3950.00 (Single User License)Global Budesonide Market Research Report 2025
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Published: 2025-01-16
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now